MT10109L in the Treatment of Glabellar Lines
Public ClinicalTrials.gov record NCT03795922. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of MT10109L (NivobotulinumtoxinA) for the Treatment of Glabellar Lines
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the safety and efficacy of MT10109L in the treatment of glabellar lines (GL) in participants with moderate to severe GL.
Study identification
- NCT ID
- NCT03795922
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 234 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 24, 2018 (Actual)
- Primary completion
- Mar 13, 2020 (Actual)
- Completion
- Jan 25, 2021 (Actual)
- Last update posted
- Jul 27, 2023
2018 – 2021
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigate MD | Scottsdale | Arizona | 85255 | — |
| Art of Skin MD | Solana Beach | California | 92075 | — |
| Weinkle Dermatology | Bradenton | Florida | 34209 | — |
| Etre, Cosmetic Dermatology and Laser Center | New Orleans | Louisiana | 70130 | — |
| Dermatology and Laser Surgery Center of New York | New York | New York | 10028 | — |
| SkinSearch of Rochester, Inc. | Rochester | New York | 14623 | — |
| M3 Wake Research, Inc. | Raleigh | North Carolina | 27612 | — |
| Aventiv Research, Inc. | Dublin | Ohio | 43016 | — |
| Westlake Dermatology & Cosmetic Surgery | Austin | Texas | 78746 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03795922, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2023 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03795922 live on ClinicalTrials.gov.